Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Knapp

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Gynecologic Oncology|May 1, 1989
Adenocarcinoma of the uterine cervix: prognostic factors and patterns of recurrenceH M Goodman, C A Buttlar, J M Niloff, et al.
Experimental Cell Research|June 1, 1995
Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs)S W Tsao, S C Mok, E G Fey, et al.
The New England Journal of Medicine|October 17, 1985
Risk of localized and widespread endometrial cancer in relation to recent and discontinued use of conjugated estrogensS Shapiro, J P Kelly, L Rosenberg, et al.
Cancer|August 15, 1980
Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinomaL M Parker, C T Griffiths, R A Yankee, et al.
JAMA|October 10, 1980
Use of thyroid supplements in relation to the risk of breast cancerS Shapiro, D Slone, D W Kaufman, et al.
Gynecologic Oncology|January 1, 1993
Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomasS W Tsao, C H Mok, R C Knapp, et al.
American Journal of Obstetrics and Gynecology|August 1, 1988
Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant diseaseG D Malkasian, R C Knapp, P T Lavin, et al.
Cancer Research|February 1, 1995
Evidence for a multifocal origin of papillary serous carcinoma of the peritoneumM G Muto, W R Welch, S C Mok, et al.
The New England Journal of Medicine|October 13, 1983
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancerR C Bast, T L Klug, E St John, et al.
American Journal of Epidemiology|January 1, 1983
Risk factors for breast cancerS P Helmrich, S Shapiro, L Rosenberg, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Gynecologic Oncology|May 1, 1989
Adenocarcinoma of the uterine cervix: prognostic factors and patterns of recurrenceH M Goodman, C A Buttlar, J M Niloff, et al.
Experimental Cell Research|June 1, 1995
Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs)S W Tsao, S C Mok, E G Fey, et al.
The New England Journal of Medicine|October 17, 1985
Risk of localized and widespread endometrial cancer in relation to recent and discontinued use of conjugated estrogensS Shapiro, J P Kelly, L Rosenberg, et al.
Cancer|August 15, 1980
Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinomaL M Parker, C T Griffiths, R A Yankee, et al.
JAMA|October 10, 1980
Use of thyroid supplements in relation to the risk of breast cancerS Shapiro, D Slone, D W Kaufman, et al.
Gynecologic Oncology|January 1, 1993
Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomasS W Tsao, C H Mok, R C Knapp, et al.
American Journal of Obstetrics and Gynecology|August 1, 1988
Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant diseaseG D Malkasian, R C Knapp, P T Lavin, et al.
Cancer Research|February 1, 1995
Evidence for a multifocal origin of papillary serous carcinoma of the peritoneumM G Muto, W R Welch, S C Mok, et al.
The New England Journal of Medicine|October 13, 1983
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancerR C Bast, T L Klug, E St John, et al.
American Journal of Epidemiology|January 1, 1983
Risk factors for breast cancerS P Helmrich, S Shapiro, L Rosenberg, et al.
Pageof 9